CD4+T cell-mediated HER-2/neu-specific tumor rejection in the absence of B cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD4+T cell-mediated HER-2/neu-specific tumor rejection in the absence of B cells

Published:2003-12-22 Issue:2 Volume:109 Page:259-264
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Lindencrona Jan Alvar,Preiss Susanne,Kammertoens Thomas,Schüler Thomas,Piechocki Marie,Wei Wei-Zen,Seliger Barbara,Blankenstein Thomas,Kiessling Rolf

Funder

Swedish Cancer Society

Cancer Society in Stockholm

King Gustaf V Jubilee Fund

European Community

Swedish Research Council

Wallenberg Foundation

Swedish Foundation for Strategic Research

Deutsche Krebshilfe

Dr. Mildred-Scheel-Stiftung, e.V.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference27 articles.

1. Cellular immunity to the Her-2/neu protooncogene;Kiessling;Adv Cancer Res,2002

2. In vitro generation of human cytolytic T-cells specific for peptides derived from the HER-2/neu protooncogene protein;Disis;Cancer Res,1994

3. Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients;Knutson;J Clin Invest,2001

4. Vaccination with cytoplasmic erbb-2 DNA protects mice from mammary tumor growth without anti-erbb-2 antibody;Pilon;J Immunol,2001

5. Vaccination with the extracellular domain of p185neu prevents mammary tumor development in neu transgenic mice;Esserman;Cancer Immunol Immunother,1999

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene Gun Her2/neu DNA Vaccination: Evaluation of Vaccine Efficacy in a Syngeneic Her2/neu Mouse Tumor Model;Methods in Molecular Biology;2022

2. Immunotherapy for the Breast Cancer treatment: Current Evidence and Therapeutic Options;Endocrine, Metabolic & Immune Disorders - Drug Targets;2021-04-26

3. A poly-neoantigen DNA vaccine synergizes with PD-1 blockade to induce T cell-mediated tumor control;OncoImmunology;2019-09-02

4. Breast Cancer Vaccines: New Insights;Frontiers in Endocrinology;2017-10-13

5. Molecular Adjuvants for DNA Vaccines;Current Issues in Molecular Biology;2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3